Omitting Surgery May Be Safe in Early BC After pCR

A small trial has helped to further identify women who can safely skip surgery after neoadjuvant therapy for early breast cancer.

Related Keywords

Houston ,Texas ,United States ,Henrym Kuerer ,Ava Kwong ,National Cancer Institute ,European Society For Medical Oncology ,Astrazeneca ,Md Anderson Cancer Center ,University Of Hong Kong ,Cancer Center ,European Society ,Medical Oncology ,Hong Kong ,National Cancer ,Breast Cancer ,Alignant Breast Neoplasm ,Breast Surgery ,Neoadjuvant ,Surgery ,Breast ,Cancer ,Alignant Neoplasia ,Arcinoma ,Genomics ,Genomic Medicine ,Edicine Genomic ,Pcr ,Polymerase Chain Reaction ,Circulating Tumor Cells Ctcs ,Tumor ,Genetic Testing ,